日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reverse pharmacology based clinical protocols for noninvasive integrative management of low grade cervical precancer lesions: Rationale and outcomes

基于逆向药理学的非侵入性综合治疗低级别宫颈癌前病变的临床方案:理论基础及疗效

Joshi, J V; Raut, A A; Paradkar, P H; Jagtap, S S

IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity.

IPS-1 在 I 型干扰素依赖性和非依赖性抗癌活性中差异性地诱导 TRAIL、BCL2、BIRC3 和 PRKCE

Kumar S, Ingle H, Mishra S, Mahla R S, Kumar A, Kawai T, Akira S, Takaoka A, Raut A A, Kumar H